Geode Capital Management’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-605,753
| Closed | -$48.4M | – | 4755 |
|
|
2021
Q1 | $48.4M | Buy |
605,753
+45,951
| +8% | +$3.59M | 0.01% | 1264 |
|
|
2020
Q4 | $44.1M | Buy |
559,802
+32,623
| +6% | +$1.91M | 0.01% | 1191 |
|
|
2020
Q3 | $23.2M | Sell |
527,179
-13,354
| -2% | -$658K | ﹤0.01% | 1426 |
|
|
2020
Q2 | $23.9M | Buy |
540,533
+86,405
| +19% | +$3.22M | 0.01% | 1376 |
|
|
2020
Q1 | $16.3M | Buy |
454,128
+17,987
| +4% | +$1.02M | ﹤0.01% | 1438 |
|
|
2019
Q4 | $30.9M | Buy |
436,141
+14,474
| +3% | +$1.05M | 0.01% | 1270 |
|
|
2019
Q3 | $31.5M | Buy |
421,667
+13,969
| +3% | +$1.18M | 0.01% | 1166 |
|
|
2019
Q2 | $32.9M | Buy |
407,698
+20,625
| +5% | +$1.45M | 0.01% | 1142 |
|
|
2019
Q1 | $25.9M | Sell |
387,073
-19,263
| -5% | -$1.46M | 0.01% | 1244 |
|
|
2018
Q4 | $30.3M | Buy |
406,336
+24,177
| +6% | +$2M | 0.01% | 1005 |
|
|
2018
Q3 | $35.2M | Buy |
382,159
+43,620
| +13% | +$4.15M | 0.01% | 1019 |
|
|
2018
Q2 | $33.3M | Buy |
338,539
+26,527
| +9% | +$2.97M | 0.01% | 1002 |
|
|
2018
Q1 | $34.8M | Buy |
312,012
+11,694
| +4% | +$1.31M | 0.01% | 913 |
|
|
2017
Q4 | $30.9M | Sell |
300,318
-4,524
| -1% | -$451K | 0.01% | 964 |
|
|
2017
Q3 | $28.7M | Sell |
304,842
-43,357
| -12% | -$3.42M | 0.01% | 987 |
|
|
2017
Q2 | $27.1M | Sell |
348,199
-11,459
| -3% | -$861K | 0.01% | 984 |
|
|
2017
Q1 | $28.8M | Buy |
359,658
+18,076
| +5% | +$1.44M | 0.01% | 914 |
|
|
2016
Q4 | $26.9M | Buy |
341,582
+21,109
| +7% | +$1.64M | 0.01% | 892 |
|
|
2016
Q3 | $25M | Buy |
320,473
+2,344
| +0.7% | +$170K | 0.01% | 862 |
|
|
2016
Q2 | $21.9M | Buy |
318,129
+8,107
| +3% | +$559K | 0.01% | 884 |
|
|
2016
Q1 | $22.1K | Buy |
310,022
+14,211
| +5% | +$892K | 0.01% | 862 |
|
|
2015
Q4 | $18.4M | Buy |
295,811
+7,962
| +3% | +$486K | 0.01% | 946 |
|
|
2015
Q3 | $16.3M | Buy |
287,849
+12,237
| +4% | +$648K | 0.01% | 1004 |
|
|
2015
Q2 | $14.8M | Buy |
275,612
+20,947
| +8% | +$1.02M | 0.01% | 1139 |
|
|
2015
Q1 | $12.1M | Buy |
254,665
+22,652
| +10% | +$1M | 0.01% | 1241 |
|
|
2014
Q4 | $10M | Sell |
232,013
-1,482
| -0.6% | -$60.5K | 0.01% | 1339 |
|
|
2014
Q3 | $8.03M | Sell |
233,495
-479
| -0.2% | -$16.9K | 0.01% | 1434 |
|
|
2014
Q2 | $8.57M | Buy |
233,974
+9,188
| +4% | +$312K | 0.01% | 1419 |
|
|
2014
Q1 | $7.58M | Sell |
224,786
-12,009
| -5% | -$396K | 0.01% | 1448 |
|
|
2013
Q4 | $8.03M | Buy |
236,795
+73,374
| +45% | +$2.54M | 0.01% | 1356 |
|
|
2013
Q3 | $5.21M | Buy |
163,421
+4,416
| +3% | +$117K | ﹤0.01% | 1529 |
|
|
2013
Q2 | $3.59M | Buy |
+159,005
| New | +$3.44M | ﹤0.01% | 1654 |
|
Geode Capital Management's CMD Position: Q2 2021 in Review
Geode Capital Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 605,753 shares — an estimated $48.4M sold.
Geode Capital Management first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $48.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Geode Capital Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Geode Capital Management sold 605,753 Cantel Medical Corporation shares in Q2 2021, an estimated $48.4M.
- Geode Capital Management first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Geode Capital Management's Cantel Medical Corporation position peaked at $48.4M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.